Update on Kidney Stone Management (2026 IMCU)
Learning Objectives:
- Describe the current epidemiology, common risk factors, and potential complications associated with kidney stone disease.
- Identify and explain established dietary and pharmacological interventions for the prevention of various kidney stone types.
- Evaluate the emerging evidence for Sodium-Glucose Co-transporter 2 inhibitors (SGLT2i) as an off-label adjunctive therapy for kidney stone prevention.
David S. Levy, DO, FACOI, FASN (he/him/his)
Assistant Professor of Clinical Medicine
University of Rochester School of Medicine
David S. Levy D.O., FACOI, FASN. Assistant Professor of Clinical Medicine and Associate Director of Informatics, Department of Medicine, at the University of Rochester School of Medicine in Rochester New York. Analytical and accomplished physician, with a proven track record of formal teaching, leadership and clinical expertise in internal medicine and nephrology. Strong ability to provide effective management of clinical operations including supervising diagnostic and medical processes, developing protocols and ensuring compliance with regulations. Epic Certified Physician Builder with solid training in building systems within medical records to increase physician efficiency and track quality metrics of patient care. Experience in improving patient care procedures. Strategic problem-solver with a passion for collaborative mentorship and relationship building.
Key:
Complete
Next
Failed
Available
Locked